vision

Childhood myopia, or nearsightedness, is growing rapidly in the U.S. and around the world. Researchers say kids who spend two hours outside every day, are less likely to develop the condition.

With artificial intelligence in health care on the rise, eye screenings for diabetic retinopathy are emerging as one of the first proven use cases of AI-based diagnostics in a clinical setting.

To treat amblyopia, doctors typically prescribe a patch to cover the stronger eye and make the brain learn to work with the weaker one. Virtual reality offers a new approach.

Repeated recalls of eyedrops are drawing new attention to the limited powers U.S. regulators have to oversee medical products made overseas.

U.S. health inspectors found a host of sanitation and manufacturing problems at an Indian plant that recently recalled eyedrops sold in the U.S.

Americans think losing their eyesight would be one of the worst possible health outcomes, yet millions lack a fundamental understanding of eye health.

Researchers take a small biopsy from the healthy eye, grow and expand the stem cells in a lab and then transplant them into the injured eye.

Kids are focusing too close for too long and their eyes are actually growing to focus the light for things that are near. But it’s blurring their vision for distance.

Infections from drug-resistant bacteria have caused death and illness in 68 patients several states, including Florida, the CDC says. The strain has been linked to recalled eyedrops like EzriCare Artificial Tears.

Some nasty eye infections in California led health officials to link a superbug bacteria to potentially contaminated eyedrops imported from India. At last count, 58 Americans in 13 states have been infected.